Focused Alpha »

Takeda Pharmaceutical shares owned by Focused Alpha

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Focused Alpha from 13F filings

Historical chart of Focused Alpha investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Focused Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Focused Alpha

Quarter filed Position value Share count Share price at filing
2025-12-31 $221k 14k 15.59

More positions owned by Focused Alpha

Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Vanguard Index Fds Value Etf (VTV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Goldman Sachs Etf Tr Ultra Short Bond (GSST)
NVIDIA Corporation (NVDA)
Mastercard Incorporated Cl A (MA)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange Traded F Active Growth (JGRO)

View all positions for Focused Alpha

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Goldman Sachs Group
FMR
UBS Group
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors
Managed Asset Portfolios

View all funds holding Takeda Pharmaceutical